Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized,Blind, Positive-controlled Phase III Clinical Trial to Evaluate the Safety and Immunogencity of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine CRM197,TT in Healthy People Aged 6 Weeks and Above

Next Previous
Trial Profile

A Randomized,Blind, Positive-controlled Phase III Clinical Trial to Evaluate the Safety and Immunogencity of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine CRM197,TT in Healthy People Aged 6 Weeks and Above

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 Apr 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pneumococcal 13-valent vaccine conjugate Sinovac Biotech (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate
  • Indications Bacterial infections; Pneumococcal infections; Streptococcal infections
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Acronyms PICTPCV13i
  • Sponsors Tianjin CanSino Biotechnology

Most Recent Events

  • 01 Apr 2024 Status changed from active, no longer recruiting to completed.
  • 28 Oct 2022 Planned End Date changed from 1 Apr 2023 to 30 Nov 2024.
  • 28 Oct 2022 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top